Tyche Industries

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE443B01012
  • NSEID:
  • BSEID: 532384
INR
114.35
0.00 (0.00%)
BSENSE

Dec 05

BSE+NSE Vol: 25

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

25 (-98.14%) Volume

Shareholding (Sep 2025)

FII

0.00%

Held by 0 FIIs

DII

0.00%

Held by 0 DIIs

Promoter

61.97%

Who are in the management team of Tyche Industries?

06-Jun-2025

As of March 2023, the management team of Tyche Industries includes G Ganesh Kumar (Chairman & Managing Director), Boosa Eswar (Independent Director), P Vijaya Lakshmi (Director), Panchakarla Sai Sudhakar (Independent Director), G Sandeep Kumar (Executive Director), Venkataraju Gupta Kollepalli (Non-Executive Director), Satya Ranjan Jena (Company Secretary & Compliance Officer), and Srinivas Gelli (Non-Executive Director).

As of March 2023, the management team of Tyche Industries includes the following individuals:<BR><BR>1. G Ganesh Kumar - Chairman & Managing Director<BR>2. Boosa Eswar - Independent Director<BR>3. P Vijaya Lakshmi - Director<BR>4. Panchakarla Sai Sudhakar - Independent Director<BR>5. G Sandeep Kumar - Executive Director<BR>6. Venkataraju Gupta Kollepalli - Non Executive Director<BR>7. Satya Ranjan Jena - Company Secretary & Compliance Officer<BR>8. Srinivas Gelli - Non Executive Director<BR><BR>These members play various roles in the governance and management of the company.

Read More

When is the next results date for Tyche Industries?

06-Jun-2025

No Upcoming Board Meetings

Has Tyche Industries declared dividend?

06-Jun-2025

Yes, Tyche Industries has declared a dividend of 25% (amounting to $2.5 per share) with an ex-date of September 20, 2024. While the dividend yield is 1.79%, total returns have shown significant volatility, with negative returns in shorter periods and more favorable outcomes over the longer term.

Tyche Industries has declared a dividend.<BR><BR>Dividend Details:<BR>- Percentage announced: 25%<BR>- Amount per share: 2.5<BR>- Ex-date: 20 Sep 24<BR><BR>Dividend Yield: 1.79%.<BR><BR>Total Returns by Period:<BR>In the 6-month period, the price return was -34.69%, the dividend return was 0%, resulting in a total return of -34.69%.<BR><BR>For the 1-year period, the price return was -22.71%, the dividend return was 1.41%, leading to a total return of -21.3%.<BR><BR>Over 2 years, the price return was -23.92%, the dividend return was 2.40%, culminating in a total return of -21.52%.<BR><BR>In the 3-year period, the price return was 7.64%, the dividend return was 5.14%, resulting in a total return of 12.78%.<BR><BR>For the 4-year period, the price return was -36.26%, the dividend return was 3.09%, leading to a total return of -33.17%.<BR><BR>In the 5-year period, the price return was 26.65%, the dividend return was 6.46%, resulting in a total return of 33.11%.<BR><BR>Overall, Tyche Industries has declared a dividend, but the total returns over various periods show significant volatility, with negative returns in the shorter terms and a more favorable outcome over the longer term.

Read More

Who are the peers of the Tyche Industries?

03-Jun-2025

Tyche Industries' peers include Sun Pharma, Divi's Lab, Cipla, Torrent Pharma, Dr Reddy's Labs, BDH Industries, Lactose (India), Sotac Pharma, and Vaishali Pharma. Among these, Sun Pharma and Cipla show excellent management and growth, while Tyche Industries has a below-average growth rate and a 1-year return of -19.55%.

Peers: The peers of Tyche Industries are Sun Pharma.Inds., Divi's Lab., Cipla, Torrent Pharma, Dr Reddy's Labs, BDH Industries, Lactose (India), Sotac Pharma., and Vaishali Pharma.<BR><BR>Quality Snapshot: Excellent management risk is observed at Sun Pharma.Inds., Divi's Lab., Cipla, Torrent Pharma, Dr Reddy's Labs, and BDH Industries, while Below Average management risk is found at Lactose (India), Sotac Pharma., and Vaishali Pharma. Growth is Excellent for Sun Pharma.Inds., Cipla, and Dr Reddy's Labs, while Below Average growth is noted for Divi's Lab., Torrent Pharma, BDH Industries, Tyche Industries, Lactose (India), Vaishali Pharma, and the rest. Excellent capital structure is seen at Sun Pharma.Inds., Divi's Lab., Cipla, Dr Reddy's Labs, BDH Industries, and Tyche Industries, while Below Average capital structure is present at Lactose (India), Sotac Pharma., and Vaishali Pharma.<BR><BR>Return Snapshot: Divi's Lab. has the highest 1-year return at 51.96%, while Lactose (India) has the lowest at -35.55%. Tyche Industries' 1-year return is -19.55%, which is higher than Lactose (India) but lower than all other peers. Additionally, BDH Industries, Lactose (India), and Tyche Industries have negative six-month returns.

Read More

What is the technical trend for Tyche Industries?

09-Jun-2025

As of June 2, 2025, Tyche Industries shows a mildly bearish trend overall, with mixed signals from key indicators like MACD and KST, while daily moving averages remain bearish.

As of 2 June 2025, the technical trend for Tyche Industries has changed from bearish to mildly bearish. The weekly MACD indicates a mildly bullish stance, while the monthly MACD remains bearish. The RSI shows no signal on the weekly chart but is bullish on the monthly chart. Bollinger Bands are mildly bearish on both weekly and monthly time frames. Daily moving averages are bearish, and the KST is mildly bullish weekly but bearish monthly. Dow Theory shows no trend in both weekly and monthly perspectives. Overall, the current technical stance is mildly bearish, with key indicators being the bearish moving averages and the mixed signals from MACD and KST.

Read More

What does Tyche Industries do?

17-Jul-2025

Tyche Industries Ltd is a micro-cap pharmaceutical company specializing in the manufacture of Glucosamine Hydrochloride and bulk drug intermediates. As of March 2025, it reported net sales of 124 Cr and a net profit of 9 Cr, with a market cap of INR 149 Cr.

Overview: <BR>Tyche Industries Ltd is a micro-cap company in the Pharmaceuticals & Biotechnology industry, primarily engaged in the manufacture of Glucosamine Hydrochloride and bulk drug intermediates.<BR><BR>History: <BR>Incorporated on July 23, 1998, Tyche Industries Limited was formerly known as Siris Soft Limited. The latest quarterly results reported net sales and profit for March 2025.<BR><BR>Financial Snapshot: <BR>Most recent Net Sales: 124 Cr (Quarterly Results - Mar 2025) <BR>Most recent Net Profit: 9 Cr (Quarterly Results - Mar 2025) <BR>Market-cap value: INR 149 Cr (Micro Cap)<BR><BR>Key Metrics: <BR>P/E: 12.00 <BR>Industry P/E: 47 <BR>Dividend Yield: 1.76% <BR>Debt Equity: -0.62 <BR>Return on Equity: 9.07% <BR>Price to Book: 1.06 <BR><BR>Contact Details: <BR>Address: H No C-21/A Road No 9, Film Nagar Jubilee Hills Hyderabad Telangana : 500096 <BR>Tel: 91-40-23541688/23540933 <BR>Email: CS@tycheindustries.net <BR>Website: http://wwww.tycheindustries.net

Read More

Who are the top shareholders of the Tyche Industries?

17-Jul-2025

The top shareholders of Tyche Industries include Silver Oak Technologies Private Limited with 19.31%, followed by Plutus Techlabs Private Limited at 6.4%. Individual investors collectively own 26.91%, and there are no mutual funds or foreign institutional investors involved.

The top shareholders of Tyche Industries include Silver Oak Technologies Private Limited, which holds the highest stake at 19.31%. The company is primarily owned by its promoters, and there are no pledged promoter holdings. In terms of public shareholders, Plutus Techlabs Private Limited is the largest, with a holding of 6.4%. Additionally, individual investors collectively own 26.91% of the company. There are currently no mutual funds or foreign institutional investors holding shares in Tyche Industries.

Read More

How big is Tyche Industries?

24-Jul-2025

As of 24th July, Tyche Industries Ltd has a market capitalization of 144.00 Cr, with recent net sales of 65.48 Cr and a net profit of 12.40 Cr. Shareholder's funds are 126.74 Cr, and total assets amount to 136.90 Cr.

As of 24th July, Tyche Industries Ltd has a market capitalization of 144.00 Cr, which categorizes it as a Micro Cap company.<BR><BR>In the latest four quarters, Tyche Industries reported Net Sales of 65.48 Cr and a Net Profit of 12.40 Cr.<BR><BR>The latest annual period for the balance sheet is March 2024, with Shareholder's Funds amounting to 126.74 Cr and Total Assets of 136.90 Cr.

Read More

Are Tyche Industries latest results good or bad?

13-Aug-2025

Tyche Industries' latest results are disappointing, with net sales down 22.4% and Profit After Tax falling 21.6% compared to previous quarters. The reliance on non-operating income raises concerns, leading to a 'Sell' rating from MarketsMOJO.

Tyche Industries has reported disappointing financial results for the quarter ending June 2025. The company's net sales decreased significantly by 22.4% compared to the average of the previous four quarters, totaling Rs 12.70 crore. This decline indicates ongoing challenges in generating revenue.<BR><BR>Profit After Tax (PAT) also fell to Rs 2.43 crore, reflecting a 21.6% drop from the average PAT of the prior quarters. This decline in profitability raises concerns about the company's financial health.<BR><BR>Moreover, a notable portion of the company's Profit Before Tax (PBT)—54.29%—came from non-operating income, suggesting a reliance on income sources outside of its core business activities. This dependency may not be sustainable in the long run.<BR><BR>Overall, the financial results indicate a negative trend, and the stock has been rated as a 'Sell' by MarketsMOJO, which reflects the current sentiment surrounding Tyche Industries.

Read More

How has been the historical performance of Tyche Industries?

15-Nov-2025

Tyche Industries has experienced declining net sales and profits from March 2023 to March 2025, with net sales dropping from INR 75.39 crore to INR 65.47 crore and profit after tax decreasing from INR 14.17 crore to INR 12.41 crore. However, total assets increased from INR 136.72 crore to INR 147.41 crore, primarily due to a rise in cash reserves.

Answer:<BR>The historical performance of Tyche Industries shows a fluctuating trend in key financial metrics over the years, with notable changes in net sales, profits, and assets.<BR><BR>Breakdown:<BR>Tyche Industries' net sales have seen a decline from INR 75.39 crore in March 2023 to INR 65.47 crore in March 2025, reflecting a downward trend over the last two years. The total operating income followed a similar pattern, decreasing from INR 75.39 crore in March 2023 to INR 65.47 crore in March 2025. Operating profit (PBDIT) also decreased from INR 20.98 crore in March 2023 to INR 18.71 crore in March 2025, indicating a reduction in profitability. The profit before tax showed a decline from INR 19.08 crore in March 2023 to INR 16.71 crore in March 2025, while profit after tax slightly decreased from INR 14.17 crore to INR 12.41 crore during the same period. On the balance sheet, total assets increased from INR 136.72 crore in March 2023 to INR 147.41 crore in March 2025, driven by growth in cash and bank balances, which rose from INR 69.28 crore to INR 84.26 crore. Total liabilities also increased from INR 136.72 crore to INR 147.41 crore, with no long-term or short-term borrowings reported throughout the years. Overall, Tyche Industries has experienced a mixed performance with declining sales and profits but an increase in total assets and cash reserves.

Read More

Should I buy, sell or hold Tyche Industries?

16-Nov-2025

Is Tyche Industries overvalued or undervalued?

20-Nov-2025

As of November 19, 2025, Tyche Industries is considered overvalued with a PE ratio of 13.01 and an EV to EBITDA of 15.16, lagging behind peers like Solar Industries and Godrej Industries, and has a year-to-date return of -36.01% compared to the Sensex's 9.02%.

As of 19 November 2025, Tyche Industries has moved from a fair to an expensive valuation grade. The company is currently considered overvalued based on its financial ratios and peer comparisons. Key ratios include a PE ratio of 13.01, an EV to EBITDA of 15.16, and a Price to Book Value of 0.89, which indicate that the stock is trading at a premium compared to its earnings and book value.<BR><BR>In comparison to its peers, Tyche Industries' valuation appears less favorable; for instance, Solar Industries has a PE ratio of 94.38 and an EV to EBITDA of 58.08, while Godrej Industries shows a more attractive PE of 37.28 and an EV to EBITDA of 40.76. The significant divergence in valuation metrics suggests that Tyche Industries is not only overvalued relative to its own historical performance but also compared to its industry peers. Additionally, the company's recent stock performance has lagged behind the Sensex, with a year-to-date return of -36.01% compared to the Sensex's 9.02%, reinforcing the perception of overvaluation.

Read More

Why is Tyche Industries falling/rising?

03-Dec-2025

As of 03-Dec, Tyche Industries Ltd's stock price is Rs 120.00, reflecting a decline of -0.5% and reaching a new 52-week low of Rs 114. The company has significantly underperformed, with a -43.46% return over the past year and negative results for the last three quarters, indicating weak financial health and growth prospects.

As of 03-Dec, Tyche Industries Ltd is experiencing a decline in its stock price, currently at Rs 120.00, which reflects a change of -0.6 (-0.5%). The stock has been on a downward trend, having fallen for the last four consecutive days, resulting in a total decline of -2.08% during this period. Additionally, the stock has reached a new 52-week low of Rs 114 today.<BR><BR>The company's performance over various time frames indicates significant underperformance. Over the past year, Tyche Industries has generated a return of -43.46%, while its net sales have decreased at an annual rate of -4.77% and operating profit has fallen by -27.59% over the last five years. Furthermore, the company has reported negative results for the last three consecutive quarters, with a notable decline in profit after tax (PAT) of -45.45% in the latest six months.<BR><BR>Investor participation has also diminished, as evidenced by a delivery volume of 379 on December 2, which is down by -72.58% compared to the five-day average. The stock is trading below all key moving averages, indicating a bearish trend. Despite having a low debt-to-equity ratio, the overall financial health and growth prospects of Tyche Industries appear weak, contributing to the stock's decline.

Read More
iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Dashboard
1

Poor long term growth as Net Sales has grown by an annual rate of -4.77% and Operating profit at -27.59% over the last 5 years

 
2

The company has declared Negative results for the last 3 consecutive quarters

3

With ROE of 6.8, it has a Expensive valuation with a 0.8 Price to Book Value

4

Below par performance in long term as well as near term

stock-summaryMojo Parameters
Mojo Parameters
Loading Valuation Snapshot...
Stock DNA
stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

INR 117 Cr (Micro Cap)

stock-summary
P/E

12.00

stock-summary
Industry P/E

27

stock-summary
Dividend Yield

2.50%

stock-summary
Debt Equity

-0.19

stock-summary
Return on Equity

6.85%

stock-summary
Price to Book

0.87

Revenue and Profits:
Net Sales:
14 Cr
(Quarterly Results - Sep 2025)
Net Profit:
2 Cr
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
Dividend Yield (2.5%)
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-17.11%
2.21%
-14.9%
6 Months
-18.26%
2.15%
-16.11%
1 Year
-46.12%
1.45%
-44.67%
2 Years
-37.56%
3.12%
-34.44%
3 Years
-12.11%
5.62%
-6.49%
4 Years
-32.08%
5.52%
-26.56%
5 Years
-48.08%
4.51%
-43.57%

Latest dividend: 3 per share ex-dividend date: Sep-19-2025

Risk Adjusted Returns v/s stock-summary
Returns Beta
Icon
Beta has not been calculated since enough price history is not available
stock-summaryNews & Corporate Actions
News

Why is Tyche Industries falling/rising?

Announcements stock-summary

Announcement under Regulation 30 (LODR)-Newspaper Publication

15-Nov-2025 | Source : BSE

Newspaper publication of Financial Results for the 2nd quarter and half-year ended September 30 2025.

Disclosure Under Regulation 30(5) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015

13-Nov-2025 | Source : BSE

Disclosure under Regulation 30(5) of SEBI(LODR) Regulations 2015.

Un-Audited Financial Results For The Quarter And Half Year Ended 30Th September 2025.

13-Nov-2025 | Source : BSE

Un-Audited Financial Results for the quarter and half-year ended 30th September 2025.

Corporate Actions stock-summary
stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

Tyche Industries Ltd has declared 30% dividend, ex-date: 19 Sep 25

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

No Rights history available

stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
-4.77%
EBIT Growth (5y)
-27.59%
EBIT to Interest (avg)
10.91
Debt to EBITDA (avg)
0.16
Net Debt to Equity (avg)
-0.19
Sales to Capital Employed (avg)
0.63
Tax Ratio
26.04%
Dividend Payout Ratio
24.77%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
30.71%
ROE (avg)
10.52%
Valuation key factors
Factor
Value
P/E Ratio
12
Industry P/E
27
Price to Book Value
0.84
EV to EBIT
20.03
EV to EBITDA
14.09
EV to Capital Employed
0.80
EV to Sales
1.60
PEG Ratio
NA
Dividend Yield
2.60%
ROCE (Latest)
4.01%
ROE (Latest)
6.85%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Bearish
Dow Theory
Mildly Bearish
Mildly Bearish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Sep 2025stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Promoters

Pledged Promoter Holdings

None

Mutual Funds

Held by 0 Schemes

FIIs

Held by 0 FIIs

Promoter with highest holding

Silver Oak Technologies Private Limited (19.31%)

Highest Public shareholder

Plutus Techlabs Private Limited (6.4%)

Individual Investors Holdings

26.67%

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Standalone) - Sep'25 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Sep 2025 is 11.50% vs 2.67% in Jun 2025",
        "dir": 1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "QoQ Growth in quarter ended Sep 2025 is -37.45% vs 158.51% in Jun 2025",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Sep'25",
        "Jun'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "14.16",
          "val2": "12.70",
          "chgp": "11.50%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-0.13",
          "val2": "1.94",
          "chgp": "-106.70%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "1.52",
          "val2": "2.43",
          "chgp": "-37.45%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-0.92%",
          "val2": "15.28%",
          "chgp": "-16.20%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "header": "Half Yearly Results Snapshot (Standalone) - Sep'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": " Growth in half year ended Sep 2025 is -25.51% vs 8.98% in Sep 2024",
        "dir": -1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": " Growth in half year ended Sep 2025 is -41.22% vs 14.87% in Sep 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Sep'25",
        "Sep'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "26.86",
          "val2": "36.06",
          "chgp": "-25.51%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "1.81",
          "val2": "7.33",
          "chgp": "-75.31%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "-0.70",
          "chgp": "100.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "3.95",
          "val2": "6.72",
          "chgp": "-41.22%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "6.74%",
          "val2": "20.33%",
          "chgp": "-13.59%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "header": "Nine Monthly Results Snapshot (Standalone) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in nine months ended Dec 2024 is -2.71% vs 10.40% in Dec 2023",
        "dir": -1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "YoY Growth in nine months ended Dec 2024 is 13.02% vs 0.70% in Dec 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "53.81",
          "val2": "55.31",
          "chgp": "-2.71%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "12.17",
          "val2": "10.77",
          "chgp": "13.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "-0.70",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "11.46",
          "val2": "10.14",
          "chgp": "13.02%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "22.62%",
          "val2": "19.47%",
          "chgp": "3.15%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Standalone) - Mar'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2025 is -5.81% vs -7.80% in Mar 2024",
        "dir": 1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2025 is 1.39% vs -13.62% in Mar 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Mar'25",
        "Mar'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "65.47",
          "val2": "69.51",
          "chgp": "-5.81%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "11.29",
          "val2": "12.65",
          "chgp": "-10.75%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "12.41",
          "val2": "12.24",
          "chgp": "1.39%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "17.24%",
          "val2": "18.20%",
          "chgp": "-0.96%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Standalone) - Sep'25 - QoQstock-summary
Sep'25
Jun'25
Change(%)
Net Sales
14.16
12.70
11.50%
Operating Profit (PBDIT) excl Other Income
-0.13
1.94
-106.70%
Interest
0.00
0.00
Exceptional Items
0.00
0.00
Standalone Net Profit
1.52
2.43
-37.45%
Operating Profit Margin (Excl OI)
-0.92%
15.28%
-16.20%
Values in Rs Cr.
Direction Arrows
Net Sales

QoQ Growth in quarter ended Sep 2025 is 11.50% vs 2.67% in Jun 2025

Direction Arrows
Standalone Net Profit

QoQ Growth in quarter ended Sep 2025 is -37.45% vs 158.51% in Jun 2025

Half Yearly Results Snapshot (Standalone) - Sep'25stock-summary
Sep'25
Sep'24
Change(%)
Net Sales
26.86
36.06
-25.51%
Operating Profit (PBDIT) excl Other Income
1.81
7.33
-75.31%
Interest
0.00
0.00
Exceptional Items
0.00
-0.70
100.00%
Standalone Net Profit
3.95
6.72
-41.22%
Operating Profit Margin (Excl OI)
6.74%
20.33%
-13.59%
Values in Rs Cr.
Direction Arrows
Net Sales

Growth in half year ended Sep 2025 is -25.51% vs 8.98% in Sep 2024

Direction Arrows
Standalone Net Profit

Growth in half year ended Sep 2025 is -41.22% vs 14.87% in Sep 2024

Nine Monthly Results Snapshot (Standalone) - Dec'24stock-summary
Dec'24
Dec'23
Change(%)
Net Sales
53.81
55.31
-2.71%
Operating Profit (PBDIT) excl Other Income
12.17
10.77
13.00%
Interest
0.00
0.00
Exceptional Items
-0.70
0.00
Standalone Net Profit
11.46
10.14
13.02%
Operating Profit Margin (Excl OI)
22.62%
19.47%
3.15%
Values in Rs Cr.
Direction Arrows
Net Sales

YoY Growth in nine months ended Dec 2024 is -2.71% vs 10.40% in Dec 2023

Direction Arrows
Standalone Net Profit

YoY Growth in nine months ended Dec 2024 is 13.02% vs 0.70% in Dec 2023

Annual Results Snapshot (Standalone) - Mar'25stock-summary
Mar'25
Mar'24
Change(%)
Net Sales
65.47
69.51
-5.81%
Operating Profit (PBDIT) excl Other Income
11.29
12.65
-10.75%
Interest
0.00
0.00
Exceptional Items
0.00
0.00
Standalone Net Profit
12.41
12.24
1.39%
Operating Profit Margin (Excl OI)
17.24%
18.20%
-0.96%
Values in Rs Cr.
Direction Arrows
Net Sales

YoY Growth in year ended Mar 2025 is -5.81% vs -7.80% in Mar 2024

Direction Arrows
Standalone Net Profit

YoY Growth in year ended Mar 2025 is 1.39% vs -13.62% in Mar 2024

stock-summaryCompany CV
About Tyche Industries Ltd stock-summary
stock-summary
Tyche Industries Ltd
Micro Cap
Pharmaceuticals & Biotechnology
Tyche Industries Limited (formerly known as Siris Soft Limited) was incorporated on Jul' 23, 1998. TIL is one of the largest manufacturers in India of Glucosamine Hydrochloride and corresponding sodium and potassium salts which are mainly exported to USA and Europe. Company's operations are predominantly related to the manufacture of bulk drugs intermediates. The company has established two advanced development centers in the area of e-commerce in New Jersey, USA and Hyderabad.
Company Coordinates stock-summary
Company Details
H No C-21/A Road No 9, Film Nagar Jubilee Hills Hyderabad Telangana : 500096
stock-summary
Tel: 91-40-23541688/23540933
stock-summary
CS@tycheindustries.net
Registrar Details
Cil Securities Ltd , 214 Raghava Ratna Towers , Chirag Ali Lane, Abidas, Hyderabad